It is clear that the MS Society wants to delay a pivotal CCSVI treatment trial for as long as possible as demonstrated by the Multiple Sclerosis Society/ Canadian Institutes for Health Research Report on CCSVI Treatment Research (http://www.direct-ms.org/magazines/Beaudet%20Executive%20Summary.pdf) .

In contrast, Direct-MS sees the need for a CCSVI treatment trial as soon as possible. Such a trial will be necessary before the medical profession/government bodies accept that CCSVI treatment is of value for MS. The sooner the trial is completed, the sooner CCSVI treatment will be widely available in Canada and the USA.

Direct-MS is spearheading an effort to raise enough money to fund a proper clinical trial to test the effectiveness of CCSVI. Such a trial will likely cost  ~ 5 million dollars. Because of the critical importance of such CCSVI clinical research, all non-directed donations to Direct-MS over the next 24 months will go to this project.

Importantly, Direct-MS is a volunteer, “flow through” charity and every dollar donated will go to research. We take nothing off the top and this approach contrasts sharply with that of the MS Society which uses the majority of all money collected for internal uses (salaries, fund raising, administration, travel) rather than research.

If you wish to donate to Direct-MS, this can be done either through our website (http://www.direct-ms.org/donate.html) or by sending a cheque to Direct-MS, 5119 Brockington Rd NW, Calgary, AB, Canada, T2L 1R7.

Direct-MS is a registered charity and a receipt for tax purposes will be issued promptly for both Canada and the USA. Please tell your friends and relatives, if they want to help persons with MS, to consider donating to Direct-MS. If we are going to reach our goal of funding a proper CCSVI treatment trial, we are going to have strong support from as many people as possible.